Centiva Capital’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-50,000
Closed -$913K 1323
2025
Q3
$913K Buy
50,000
+10,000
+25% +$165K 0.01% 513
2025
Q2
$630K Sell
40,000
-575,800
-94% -$7.32M 0.01% 847
2025
Q1
$7.81M Buy
615,800
+589,800
+2,268% +$9.26M 0.24% 40
2024
Q4
$573K Sell
26,000
-60,700
-70% -$1.28M 0.01% 740
2024
Q3
$1.54M Sell
86,700
-104,000
-55% -$1.67M 0.03% 588
2024
Q2
$3.06M Buy
+190,700
New +$3.01M 0.05% 261

Other funds holding CLMT

Centiva Capital's CLMT Position: Q2 2025 in Review

Centiva Capital sold out of Calumet Specialty Products (CLMT) in Q2 2025, closing a stake of 20,000 shares — an estimated $254K sold.

Centiva Capital first reported a position in CLMT in Q1 2025 and held it in 1 quarter. The position peaked at $254K in Q1 2025. 134 funds tracked by Wall St. Rank hold CLMT as of Q2 2025.

  • Centiva Capital reported no remaining Calumet Specialty Products position as of Q2 2025 after selling out during the quarter.
  • Centiva Capital sold 20,000 Calumet Specialty Products shares in Q2 2025, an estimated $254K.
  • Centiva Capital first reported a position in Calumet Specialty Products in Q1 2025 and held it in 1 quarter.
  • Centiva Capital's Calumet Specialty Products position peaked at $254K in Q1 2025.
  • 134 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2025.

Based on Centiva Capital's 13F filing for Q2 2025, filed 13 Aug 2025.